GSK’s $1.5b payday 

pounds sterling
Brit pharmaco scores big with discount selloff of Haleon shares British pharmaceutical giant GSK has sold off 240 million shares in consumer health operation Haleon raising around GBP804 million (AUD$1.5 billion) for itself in the process. Haleon was created in mid-2019 as the result of a spin-off of consumer health interests from both GSK but also

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous AFT to pay first dividend as income soars 20%
Next Government Aldifying pharmacy